SlideShare a Scribd company logo
1 of 55
CH.VYSHNAVI
MSC MLT
1st YEAR
 DEFINITION
 CLASSIFICATION
 Haemolytic anaemia is a condition in which red
blood cells are destroyed and removed from the
bloodstream before their normal lifespan is over.
 Haemolytic anaemia are the anaemia's that result
due to increase in the rate of red cell
destruction.
 About 1%blood is destructed ever day in normal
adult
 RBC’s normally survive 120 days .
 Bone marrow has the capacity to increase
erythropoiesis 6 - 8 times than normal.
 Therefore Hemolytic Anemia may not be seen until
the red cell lifespan is less than 30 days.
 Anemia is the result of premature destruction of red
cells exceeding the erythropoietic capacity of the
bone marrow
 When blood cells die, the body's bone marrow makes
more blood cells to replace them. However, in
haemolytic anaemia, the bone marrow can't make
red blood cells fast enough to meet the body's needs.
 An increase in destruction and production of
erythrocytes can result in a compensated haemolytic
state without anaemia being present so a called
compensated haemolytic disease
Red cell destruction
Extravascular Intravascular
RES
Haem
Globin
Plasma
iron pool
Plasma
protein pool
Protoporphyrin
Expired CO Unconjugated
bilirubin
Liver
Conjugated
bilirubin
GI tract
Urobilinogen
Faeces
Urine
Free plasma Hb
Hb- Hpt
complex
Liver
Hpt and
Hpx
Haemopexin-
methem complx
Excess Hb
Kidney
Haemosiderin
uria
Haem+globin
Hb
methem
Hemogl
obinuria
 Hemolytic anemias are classified in a variety of
ways
1. Location of hemolysis
 INTRA VASCULAR (vascular space)
 EXTRA VASCULAR(reticuloendothelial
system)
2) Source of defect causing hemolysis:
 Intra corpuscular defect
 Extra corpuscular defect
3) Mode of onset:
 Hereditary
 Acquired
Hereditary Acquired
a) Red cell Membrane defect
spherocytosis
elliptocytosis
a) Red cell Enzyme deficiency
G-6-PD deficiency
PK deficiency
a) Hemoglobin abnormalities
 Deficient globin synthesis
Thalassemias
 Structurally abnormal globins
[hemoglobinopathies]
sickle cell anemia
Unstable haemoglobins
a) Paroxysmal
nocturnal
hemoglobinuria
a) Infections
Immune haemolytic anaemia(antibody-mediated
destruction)
 Autoimmune haemolytic anaemia
Warm antibody auto immune haemolytic anaemia
Cold antibody auto immune haemolytic anaemia
Paroxysmal cold haemoglobinuria
 Alloimmune haemolytic anaemia
Haemolytic disease of the newborn
Haemolytic transfusion reactions : mismatched blood
transfusion
Microangiopathic haemolytic anaemia
 Disseminated intra vascular coagulation(DIC)
 Hemolytic uremic syndrome
 Thrombotic thrombocytopenic purpura
Sequestration(hyperspleenism & Spleenomegaly)
Drugs and chemicals
Physical/chemical trauma
 Thermal injury/burns
 March haemoglobinuria
Infections and infectious agents
 Malaria
 Clostridium infections
 Bartenellosis
 Cholera
 Animal venoms
Symtoms of Hemolysis
Paleness of skin
Fatigue
Fever
Confusion
Lightheadedness
Dizziness
Lab findings of Hemolytic Anemia
Hemoglobinuria & hemoglbinemia
Reticulocytosis
Peripheral smear- anisocytosis , poikilocytosis
Haptoglobin &hemopexin -decreased
Indirectbilirubin - increased.
 Increased serum and stored iron.
 Increased activity of bone marrow
(erythroid hyperplasia)
 Urine & feacal urobilinogen - elevated
Red cell Membrane defect
• The most common defect of red cell membrane due to
deficiency of cytoskeleton protein
- SPECTRIN
- ANKYRIN
- BAND 3
• Deficient of membrane protein causes change of shape
(round, no central pallor)
• Hereditary spherocytosis is caused by a genetic defect.
 RBCs: abnormally small, round without center
pallor.
 Osmotic fragility is increased there is shift of
curve to right
 Red cell membrane defect.
 Abnormality in the skeltal protien
Causes :
1. Defective spectrin chain
2. Abnormality in the integral protiens
3. Deficiency or defect in ‘band 4.1’
4. Abnormally permeable to Na
 Cells become elliptical due to the stress after
entering the microcirculation.
 Normal cells remains without any change.
RED CELL ENZYME DEFICIENCIES
 G-6-PD catalyses the conversion of g-6-phosphate
into ribulose 5 phosphate
 A deficiency of this enzyme reduces the ability of
RBCs to with strand the effect of various oxidising
drugs/agents, resulting in haemolytic anaemia
 Fava beans
 High fevers
 Severe infections
 Anti malarials-primaquine /quinine and choloroquine
Heinz bodies
 Pyruvate kinase deficiency is an autosomal recessive
disorder which causes congenital chronic hemolytic
anemia
 In pyruvate kinase deficiency ATP is not formed
 ATP is required for maintaining cell permeability.
 Potassium is lossed result in dehydration and
hemolysis.
 The peripheral blood film shows normocytic
normochromic anemia and increased reticulocytes
Hemoglobin abnormalities
 Substitution of valine in place
of glutamic acid at the 6th
position of β chain
 Mutant Hb is the Hb-S
 Hb-S : minimum solubility in
deoxygenated state.
 Deoxy Hb is formed and
polymerize
 RBC become stiff and sickle
shape
 Extravascular hemolysis
 Hb electrophoresis
 Sickling test
 HPLC: high –performance liquid chromatography is
useful for confirmation of diagnosis
 The thalassemia syndrome is a heterogeneous group
of inherited disorder in which one or more globin
chain synthesis is either absent or reduced.
 Thalassemia syndrome results in microcytic
hypochromic anemia due to decreased production of
hemoglobin with erythroid hyperplasia of the bone
marrow.
 The imbalance of globin synthesis causes an excess
of the normally produced globin chain. This results
in damage to red blood cells or their precursors and
hemolysis
Thalassemia syndrome is mainly of two types,
1. Alpha thalassemia
2. Beta thalassemia
β-THALASSEMIA
-Thalassemia major(homozygous)
-Thalassemia minor(trait)
-Thalassemia intermedia
α-THALASSEMIA
-Hydrops foetalis
-Hb-H disease
-α-thalassemia trait
THALASSEMIA ASOCIATED WITH OTHER
HAEMOGLOBINOPATHIES
-Hb-S thalassemia
-Hb-E thalassemia
-Hb-D thalassemia
-HPFH(Hereditary Persistence of Foetal Hb)
 Paroxysmal nocturnal hemoglobinuria is a rare ,
acquired , potentially life-threatening disease.
 Characterized by complement-induced intra vascular
hemolytic anemia(anemia due to destruction of red
blood cells in the blood stream),red urine(due to the
appearance of hemoglobin in the urine)
 It is the only hemolytic anemia caused by an intrinsic
defect in the cell
 It may develop on its own or in the context of other
bone marrow disorders such as aplastic anemia
 The gold standard is flow cytometry for CD55
and CD59 on red blood cells. Based on the levels
of these cell proteins, erythrocytes may be classified
as type I, II, or III PNH cells. Type I cells have
normal levels of CD55 and CD59; type II have
reduced levels; and type III have absent levels.The
fluorescein-labeled proaerolysin (FLAER) test is
being used more frequently to diagnose PNH on
WBCs (neutrophil and monocyte).
Immune haemolytic anaemia
 Immune haemolytic anaemia is a group of anaemia's in
which premature red cell destruction is mediated by
antibodies that bind to red cells.
 The antibodies may be either allo or auto antibodies
 The haemolysis is caused by extracorpuscular mechanism
 The site of haemolysis may be extravascular or
intravascular
 Alloimmune hemolytic anemia
 Hemolytic disease of new born
 Hemolytic transfusion reaction
 Autoimmune hemolytic anemia
 Warm antibody type (IgG antibodies active at 37Oc)
 Primary(idiopathic)
 Secondary
• Autoimmune disorders(systemic lupus
erythematosus
 In alloimmune hemolytic anemia allo-antibodies are
present either in serum or bound to red cells
Hemolytic disease of the new born(HDN)
 This is an immune hemolytic anemia which affects
the fetus and newborn baby
 It is due to maternal foetal blood group
incompatibility.
 HDN develops when mother lacks an antigen that
expressed by the foetal red cells
 HDN may be due to incompatibility of Rh type or
ABO group.
 Autoimmune hemolytic anemia(AIHA)are a group
of disorders in which antibodies against self-
antigens on the RBC membrane cause premature
destruction of RBCs.
 Interaction of the autoantibody with the red cell
antigen is dependent on the temperature, i.e. warm
or cold type.
Warm antibody type
 Warm antibody type is the most common type(50to
70%) of immunohemolytic anaemia
 This can be further divided into idiopathic
(primary)or secondary to drug exposure or
predisposing diseases.
 The antibodies are mainly of IgG type.
 The antibodies combine with red cell antigen at 34°c
(warm antibody).
 There IgG bound RBCs bind to Fc receptors on
phagocytes (macrophages)
 This remove part of red cell membrane with attached
antibody and hence known as “partial” phagocytosis.
 Progressive loss of membrane converts the red cells to
spherocytes.
 As in hereditary spherocytosis , the spleen is the
major site of removal and destruction of these
spherocytes , resulting in moderate splenomegaly..
 Antibodies bind to red cell antigens at low
temperature(4-18oc).
 The antibodies are of IgM type.
 It fixes complement and result in intra vascular
hemolysis
Clinical features
 Skin color turn white and then blue
 On rewarming it becomes red
 Numbness, tingling and pain
 Hemoglobinuria
 The autoantibodies are of IgG type and bind to red
cells at low temperatures and fix the complement.
 Massive, intermittent , acute haemolysis and
hemoglobinuria after cold exposure.
 Caused by biphasic IgG antibody (Donath-
Landsteiner antibody).
 It often follows viral infections and patient recover
within a month.
 Shear damage to red cells as the result of
endothelial cell activation/damage.
 Hallmark is presence of schistocytes on
the peripheral smear.
Causes :
- DIC=(DISSEMINATED INTRA VASCULAR
COAGULATION)
- TTP=(THROMBOTIC THROMBOCYTOPENIC
PURPURA)
- HUS=(HAEMOLYTIC UREMIC SYNDROME)
 HAEMOLYTIC UREMIC SYNDROME
 Damage to renal glomerular capillaries resulting in
agglutination of cells and thrombi formation
 THROMBOTIC THROMBOCYTOPENIC
PURPURA
 Haemolysis is due to the deposition of thrombi in
microcirculation
 DISSEMINATED INTRA VASCULAR
COAGULATION
 Activation of coagulation mechanism invivo by
thromboplastic substances resulting in the
deposition of fibrin in the microvasculature.
 RBC fragmentation due to stress produced by fibrin.
 Wintrobe’s haematology and clinical pathology
 Essentials in Hematology & Clinical pathology-
ramdas nayak ,sharada rai , astha gupta
 Practiacal pathology- Dr.k. uma chaturvedi, Dr
tejinder singh
 Text book of haematology by Mckenzie
 PARTICAL HEMATOLOGY-dacie and lewis
Hemolytic anemia (1)

More Related Content

What's hot

Acquired hemolytic anemia
Acquired hemolytic anemiaAcquired hemolytic anemia
Acquired hemolytic anemia
Praveen Nagula
 

What's hot (20)

Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Haemolytic anemia
Haemolytic anemia Haemolytic anemia
Haemolytic anemia
 
Acquired hemolytic anemia
Acquired hemolytic anemiaAcquired hemolytic anemia
Acquired hemolytic anemia
 
Autoimmune haemolytic anaemia
Autoimmune haemolytic anaemiaAutoimmune haemolytic anaemia
Autoimmune haemolytic anaemia
 
Anemia of chronic disease
Anemia of chronic diseaseAnemia of chronic disease
Anemia of chronic disease
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemolytic anemia sandip
Hemolytic anemia sandipHemolytic anemia sandip
Hemolytic anemia sandip
 
Essential thrombocytosis
Essential thrombocytosisEssential thrombocytosis
Essential thrombocytosis
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Pancytopenia
PancytopeniaPancytopenia
Pancytopenia
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 
Thalhgbopathy
ThalhgbopathyThalhgbopathy
Thalhgbopathy
 
Pancytopenia
PancytopeniaPancytopenia
Pancytopenia
 
Hemolytic Anemia Classification - By Thejus K. Thilak
Hemolytic Anemia  Classification - By Thejus K. Thilak Hemolytic Anemia  Classification - By Thejus K. Thilak
Hemolytic Anemia Classification - By Thejus K. Thilak
 
Approach to hemolytic anemias
Approach to hemolytic anemiasApproach to hemolytic anemias
Approach to hemolytic anemias
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
Anemia
AnemiaAnemia
Anemia
 

Viewers also liked

hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)
Afrina Qureshi
 
Extracorpuscular hemolytic anemia
Extracorpuscular hemolytic anemiaExtracorpuscular hemolytic anemia
Extracorpuscular hemolytic anemia
pathakadrija
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
The Medical Post
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
Dr. Rubz
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
softmail
 
Jaundice classification in adults summary
Jaundice classification in adults summaryJaundice classification in adults summary
Jaundice classification in adults summary
Dr. Rubz
 
Hemolytic anaemias
Hemolytic anaemiasHemolytic anaemias
Hemolytic anaemias
Shiz Wachira
 
immune hemolytic anemia
immune hemolytic anemiaimmune hemolytic anemia
immune hemolytic anemia
doood
 

Viewers also liked (20)

Haemolytic disorders
Haemolytic disordersHaemolytic disorders
Haemolytic disorders
 
hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)
 
Extracorpuscular hemolytic anemia
Extracorpuscular hemolytic anemiaExtracorpuscular hemolytic anemia
Extracorpuscular hemolytic anemia
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Haemolytic anaemia
Haemolytic anaemia Haemolytic anaemia
Haemolytic anaemia
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Approach to a patient with hemolytic anaemia
Approach to a patient with hemolytic anaemiaApproach to a patient with hemolytic anaemia
Approach to a patient with hemolytic anaemia
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Haemolytic anemia
Haemolytic anemiaHaemolytic anemia
Haemolytic anemia
 
Jaundice classification in adults summary
Jaundice classification in adults summaryJaundice classification in adults summary
Jaundice classification in adults summary
 
Hemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumarHemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumar
 
Hemolytic anaemias
Hemolytic anaemiasHemolytic anaemias
Hemolytic anaemias
 
12.11.08: Folate Metabolism
12.11.08: Folate Metabolism12.11.08: Folate Metabolism
12.11.08: Folate Metabolism
 
immune hemolytic anemia
immune hemolytic anemiaimmune hemolytic anemia
immune hemolytic anemia
 
Hemolytic anemia extracorpuscular defects.
Hemolytic anemia extracorpuscular defects.Hemolytic anemia extracorpuscular defects.
Hemolytic anemia extracorpuscular defects.
 

Similar to Hemolytic anemia (1)

Making the diagnosis in hematology
Making the diagnosis in hematologyMaking the diagnosis in hematology
Making the diagnosis in hematology
fracpractice
 
Blood Diseases.ppt
Blood Diseases.pptBlood Diseases.ppt
Blood Diseases.ppt
Shama
 
Making the diagnosis in hematology part 2
Making the diagnosis in hematology part 2Making the diagnosis in hematology part 2
Making the diagnosis in hematology part 2
fracpractice
 
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptxNbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
SimretSolomon5
 

Similar to Hemolytic anemia (1) (20)

Pathology of blood
Pathology of bloodPathology of blood
Pathology of blood
 
Hemolytic Anemia
Hemolytic Anemia Hemolytic Anemia
Hemolytic Anemia
 
anaemia.pptx
anaemia.pptxanaemia.pptx
anaemia.pptx
 
ACQUIRED HEMOLYTIC ANEMIA.ppt
ACQUIRED HEMOLYTIC ANEMIA.pptACQUIRED HEMOLYTIC ANEMIA.ppt
ACQUIRED HEMOLYTIC ANEMIA.ppt
 
Child with pallor & jaundice (hemolytic anemia)
Child with pallor & jaundice (hemolytic anemia)Child with pallor & jaundice (hemolytic anemia)
Child with pallor & jaundice (hemolytic anemia)
 
Making the diagnosis in hematology
Making the diagnosis in hematologyMaking the diagnosis in hematology
Making the diagnosis in hematology
 
Haematology notes
Haematology notesHaematology notes
Haematology notes
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Blood Diseases.ppt
Blood Diseases.pptBlood Diseases.ppt
Blood Diseases.ppt
 
laboratory diagnosis of hemolytic anemia-190509145931.pptx
laboratory diagnosis of hemolytic anemia-190509145931.pptxlaboratory diagnosis of hemolytic anemia-190509145931.pptx
laboratory diagnosis of hemolytic anemia-190509145931.pptx
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Making the diagnosis in hematology part 2
Making the diagnosis in hematology part 2Making the diagnosis in hematology part 2
Making the diagnosis in hematology part 2
 
7-Haemolytic anaemias a sub-type of anemia, a common blood disorder .pdf
7-Haemolytic anaemias  a sub-type of anemia, a common blood disorder .pdf7-Haemolytic anaemias  a sub-type of anemia, a common blood disorder .pdf
7-Haemolytic anaemias a sub-type of anemia, a common blood disorder .pdf
 
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptxNbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
Nbfdgghfdhhhanemia invvcdsxx87d9ysk6 pedi.pptx
 
Hemolytic Anemia dr hayder.ppt
Hemolytic Anemia dr hayder.pptHemolytic Anemia dr hayder.ppt
Hemolytic Anemia dr hayder.ppt
 
Anaemias By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
Anaemias By Dr Bashir Ahmed Dar Chinkipora Sopore KashmirAnaemias By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
Anaemias By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
 
Anemia And Its Classification
Anemia And Its ClassificationAnemia And Its Classification
Anemia And Its Classification
 
Anemia And Its Classification By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
Anemia And Its Classification By Dr Bashir Ahmed Dar Chinkipora Sopore KashmirAnemia And Its Classification By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
Anemia And Its Classification By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir
 
Shelly anemia
Shelly anemiaShelly anemia
Shelly anemia
 
Dddddxdcv in childeggffvhtwi6wi5si6ss.pptx
Dddddxdcv in childeggffvhtwi6wi5si6ss.pptxDddddxdcv in childeggffvhtwi6wi5si6ss.pptx
Dddddxdcv in childeggffvhtwi6wi5si6ss.pptx
 

Recently uploaded

一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
sovco
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
Probe Gold
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
xzxvi5zp
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
Terna SpA
 
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Klinik kandungan
 

Recently uploaded (20)

Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
 
countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 Presentation
 
Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
 
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdfITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
 
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call GirlsPremium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
 
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In DubaiDubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
 
The Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results PresentationThe Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results Presentation
 
Teekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings ResultsTeekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings Results
 
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your AreaGorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
 
AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024
 
Osisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 ResultsOsisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 Results
 
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
 
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
 

Hemolytic anemia (1)

  • 3.  Haemolytic anaemia is a condition in which red blood cells are destroyed and removed from the bloodstream before their normal lifespan is over.  Haemolytic anaemia are the anaemia's that result due to increase in the rate of red cell destruction.  About 1%blood is destructed ever day in normal adult
  • 4.  RBC’s normally survive 120 days .  Bone marrow has the capacity to increase erythropoiesis 6 - 8 times than normal.  Therefore Hemolytic Anemia may not be seen until the red cell lifespan is less than 30 days.  Anemia is the result of premature destruction of red cells exceeding the erythropoietic capacity of the bone marrow
  • 5.  When blood cells die, the body's bone marrow makes more blood cells to replace them. However, in haemolytic anaemia, the bone marrow can't make red blood cells fast enough to meet the body's needs.  An increase in destruction and production of erythrocytes can result in a compensated haemolytic state without anaemia being present so a called compensated haemolytic disease
  • 6. Red cell destruction Extravascular Intravascular RES Haem Globin Plasma iron pool Plasma protein pool Protoporphyrin Expired CO Unconjugated bilirubin Liver Conjugated bilirubin GI tract Urobilinogen Faeces Urine Free plasma Hb Hb- Hpt complex Liver Hpt and Hpx Haemopexin- methem complx Excess Hb Kidney Haemosiderin uria Haem+globin Hb methem Hemogl obinuria
  • 7.  Hemolytic anemias are classified in a variety of ways 1. Location of hemolysis  INTRA VASCULAR (vascular space)  EXTRA VASCULAR(reticuloendothelial system)
  • 8. 2) Source of defect causing hemolysis:  Intra corpuscular defect  Extra corpuscular defect 3) Mode of onset:  Hereditary  Acquired
  • 9. Hereditary Acquired a) Red cell Membrane defect spherocytosis elliptocytosis a) Red cell Enzyme deficiency G-6-PD deficiency PK deficiency a) Hemoglobin abnormalities  Deficient globin synthesis Thalassemias  Structurally abnormal globins [hemoglobinopathies] sickle cell anemia Unstable haemoglobins a) Paroxysmal nocturnal hemoglobinuria a) Infections
  • 10. Immune haemolytic anaemia(antibody-mediated destruction)  Autoimmune haemolytic anaemia Warm antibody auto immune haemolytic anaemia Cold antibody auto immune haemolytic anaemia Paroxysmal cold haemoglobinuria  Alloimmune haemolytic anaemia Haemolytic disease of the newborn Haemolytic transfusion reactions : mismatched blood transfusion
  • 11. Microangiopathic haemolytic anaemia  Disseminated intra vascular coagulation(DIC)  Hemolytic uremic syndrome  Thrombotic thrombocytopenic purpura Sequestration(hyperspleenism & Spleenomegaly) Drugs and chemicals
  • 12. Physical/chemical trauma  Thermal injury/burns  March haemoglobinuria Infections and infectious agents  Malaria  Clostridium infections  Bartenellosis  Cholera  Animal venoms
  • 13. Symtoms of Hemolysis Paleness of skin Fatigue Fever Confusion Lightheadedness Dizziness
  • 14. Lab findings of Hemolytic Anemia Hemoglobinuria & hemoglbinemia Reticulocytosis Peripheral smear- anisocytosis , poikilocytosis Haptoglobin &hemopexin -decreased Indirectbilirubin - increased.
  • 15.  Increased serum and stored iron.  Increased activity of bone marrow (erythroid hyperplasia)  Urine & feacal urobilinogen - elevated
  • 17. • The most common defect of red cell membrane due to deficiency of cytoskeleton protein - SPECTRIN - ANKYRIN - BAND 3 • Deficient of membrane protein causes change of shape (round, no central pallor) • Hereditary spherocytosis is caused by a genetic defect.
  • 18.  RBCs: abnormally small, round without center pallor.
  • 19.  Osmotic fragility is increased there is shift of curve to right
  • 20.  Red cell membrane defect.  Abnormality in the skeltal protien
  • 21. Causes : 1. Defective spectrin chain 2. Abnormality in the integral protiens 3. Deficiency or defect in ‘band 4.1’ 4. Abnormally permeable to Na  Cells become elliptical due to the stress after entering the microcirculation.  Normal cells remains without any change.
  • 22. RED CELL ENZYME DEFICIENCIES
  • 23.  G-6-PD catalyses the conversion of g-6-phosphate into ribulose 5 phosphate  A deficiency of this enzyme reduces the ability of RBCs to with strand the effect of various oxidising drugs/agents, resulting in haemolytic anaemia  Fava beans  High fevers  Severe infections  Anti malarials-primaquine /quinine and choloroquine
  • 24.
  • 26.  Pyruvate kinase deficiency is an autosomal recessive disorder which causes congenital chronic hemolytic anemia  In pyruvate kinase deficiency ATP is not formed  ATP is required for maintaining cell permeability.  Potassium is lossed result in dehydration and hemolysis.  The peripheral blood film shows normocytic normochromic anemia and increased reticulocytes
  • 27.
  • 29.  Substitution of valine in place of glutamic acid at the 6th position of β chain  Mutant Hb is the Hb-S  Hb-S : minimum solubility in deoxygenated state.  Deoxy Hb is formed and polymerize  RBC become stiff and sickle shape  Extravascular hemolysis
  • 30.
  • 31.  Hb electrophoresis  Sickling test  HPLC: high –performance liquid chromatography is useful for confirmation of diagnosis
  • 32.  The thalassemia syndrome is a heterogeneous group of inherited disorder in which one or more globin chain synthesis is either absent or reduced.  Thalassemia syndrome results in microcytic hypochromic anemia due to decreased production of hemoglobin with erythroid hyperplasia of the bone marrow.  The imbalance of globin synthesis causes an excess of the normally produced globin chain. This results in damage to red blood cells or their precursors and hemolysis
  • 33. Thalassemia syndrome is mainly of two types, 1. Alpha thalassemia 2. Beta thalassemia β-THALASSEMIA -Thalassemia major(homozygous) -Thalassemia minor(trait) -Thalassemia intermedia α-THALASSEMIA -Hydrops foetalis -Hb-H disease -α-thalassemia trait
  • 34. THALASSEMIA ASOCIATED WITH OTHER HAEMOGLOBINOPATHIES -Hb-S thalassemia -Hb-E thalassemia -Hb-D thalassemia -HPFH(Hereditary Persistence of Foetal Hb)
  • 35.
  • 36.  Paroxysmal nocturnal hemoglobinuria is a rare , acquired , potentially life-threatening disease.  Characterized by complement-induced intra vascular hemolytic anemia(anemia due to destruction of red blood cells in the blood stream),red urine(due to the appearance of hemoglobin in the urine)  It is the only hemolytic anemia caused by an intrinsic defect in the cell  It may develop on its own or in the context of other bone marrow disorders such as aplastic anemia
  • 37.
  • 38.  The gold standard is flow cytometry for CD55 and CD59 on red blood cells. Based on the levels of these cell proteins, erythrocytes may be classified as type I, II, or III PNH cells. Type I cells have normal levels of CD55 and CD59; type II have reduced levels; and type III have absent levels.The fluorescein-labeled proaerolysin (FLAER) test is being used more frequently to diagnose PNH on WBCs (neutrophil and monocyte).
  • 39. Immune haemolytic anaemia  Immune haemolytic anaemia is a group of anaemia's in which premature red cell destruction is mediated by antibodies that bind to red cells.  The antibodies may be either allo or auto antibodies  The haemolysis is caused by extracorpuscular mechanism  The site of haemolysis may be extravascular or intravascular
  • 40.  Alloimmune hemolytic anemia  Hemolytic disease of new born  Hemolytic transfusion reaction  Autoimmune hemolytic anemia  Warm antibody type (IgG antibodies active at 37Oc)  Primary(idiopathic)  Secondary • Autoimmune disorders(systemic lupus erythematosus
  • 41.  In alloimmune hemolytic anemia allo-antibodies are present either in serum or bound to red cells Hemolytic disease of the new born(HDN)  This is an immune hemolytic anemia which affects the fetus and newborn baby
  • 42.  It is due to maternal foetal blood group incompatibility.  HDN develops when mother lacks an antigen that expressed by the foetal red cells  HDN may be due to incompatibility of Rh type or ABO group.
  • 43.
  • 44.  Autoimmune hemolytic anemia(AIHA)are a group of disorders in which antibodies against self- antigens on the RBC membrane cause premature destruction of RBCs.  Interaction of the autoantibody with the red cell antigen is dependent on the temperature, i.e. warm or cold type.
  • 45. Warm antibody type  Warm antibody type is the most common type(50to 70%) of immunohemolytic anaemia  This can be further divided into idiopathic (primary)or secondary to drug exposure or predisposing diseases.  The antibodies are mainly of IgG type.  The antibodies combine with red cell antigen at 34°c (warm antibody).
  • 46.  There IgG bound RBCs bind to Fc receptors on phagocytes (macrophages)  This remove part of red cell membrane with attached antibody and hence known as “partial” phagocytosis.  Progressive loss of membrane converts the red cells to spherocytes.  As in hereditary spherocytosis , the spleen is the major site of removal and destruction of these spherocytes , resulting in moderate splenomegaly..
  • 47.  Antibodies bind to red cell antigens at low temperature(4-18oc).  The antibodies are of IgM type.  It fixes complement and result in intra vascular hemolysis
  • 48. Clinical features  Skin color turn white and then blue  On rewarming it becomes red  Numbness, tingling and pain  Hemoglobinuria
  • 49.  The autoantibodies are of IgG type and bind to red cells at low temperatures and fix the complement.  Massive, intermittent , acute haemolysis and hemoglobinuria after cold exposure.  Caused by biphasic IgG antibody (Donath- Landsteiner antibody).  It often follows viral infections and patient recover within a month.
  • 50.  Shear damage to red cells as the result of endothelial cell activation/damage.  Hallmark is presence of schistocytes on the peripheral smear.
  • 51.
  • 52. Causes : - DIC=(DISSEMINATED INTRA VASCULAR COAGULATION) - TTP=(THROMBOTIC THROMBOCYTOPENIC PURPURA) - HUS=(HAEMOLYTIC UREMIC SYNDROME)
  • 53.  HAEMOLYTIC UREMIC SYNDROME  Damage to renal glomerular capillaries resulting in agglutination of cells and thrombi formation  THROMBOTIC THROMBOCYTOPENIC PURPURA  Haemolysis is due to the deposition of thrombi in microcirculation  DISSEMINATED INTRA VASCULAR COAGULATION  Activation of coagulation mechanism invivo by thromboplastic substances resulting in the deposition of fibrin in the microvasculature.  RBC fragmentation due to stress produced by fibrin.
  • 54.  Wintrobe’s haematology and clinical pathology  Essentials in Hematology & Clinical pathology- ramdas nayak ,sharada rai , astha gupta  Practiacal pathology- Dr.k. uma chaturvedi, Dr tejinder singh  Text book of haematology by Mckenzie  PARTICAL HEMATOLOGY-dacie and lewis